ILLUSTRATIVE ANSWERI would support a limited trial rather than immediately using the tool to make final referral decisions. Patients are affected by how quickly they receive care and by the risk that a tool performs less accurately for groups that were poorly represented in its training data. Clinicians also remain responsible for safe decisions, while the hospital has an interest in reducing avoidable delay.
In favour of a trial, consistent automated screening may help staff find urgent referrals sooner and spend more time on complex cases. The strongest objection is that speed is not beneficial if errors are hidden or distributed unfairly. I would therefore keep a clinician responsible for the final priority, give staff a straightforward way to override the tool and tell patients how their information is being used.
Before wider use, the hospital should compare waiting times, missed urgent cases and false alerts with the existing process, including results for relevant patient groups rather than only an overall average. Patient and clinical representatives should help decide what level of error is acceptable. If performance is unsafe or inequitable, the trial should pause while the model or the workflow is changed. On that basis, my position is a transparent, supervised trial with clear accountability, not replacement of clinical judgement.